P-154 - Biliary tract cancer - Clinical and epidemiological profile Experience of the medical oncology service Cancer Center and Teaching Hospital of Oran

Date 04 July 2015
Event WorldGI 2015
Session Posters
Topics Hepatobiliary Cancers
Aetiology, Epidemiology, Screening and Prevention
Basic Scientific Principles
Presenter K. Rekai
Citation Annals of Oncology (2015) 26 (suppl_4): 1-100. 10.1093/annonc/mdv233
Authors K. Rekai
  • EHSO Emir Abdelkader, Oran/DZ



Biliary cancers are relatively rare, with about 3% of gastrointestinal cancers. This impact variable in the world, is increasing, especially for intrahepatic cholangiocarcinoma-carcinomas. These are most often sporadic or associated with chronic inflammatory diseases of the biliary tract.

The presentation will be our experience in the management of cancers of the biliary tract in the Medical Oncology Department


A retrospective study from January 2010 to December 2012, 65 patients were included. We analyzed the following parameters: age, sex, medical history, clinical features, imagery, classification, treatment and evolution.


Mean age Was 60 years for women and 60,5 for men. Sex ratio was 2,2.56% had a history of biliary lithiasis and 16% had a history of cancer family. The performance status was 1 in 64%. The average delay diagnosis is 3, 5 months pain, the most frequent reason for consultation (67%). Jaundice: 17.5%.

Histologic diagnosis in 54% of cases (20% surgical biopsy, 32% on room cholecystectomy or bisegmentectomy), cytological diagnosis in 34.5% of cases and no evidence in 10.9%

Histological type: Adenocarcinoma in 91.9%.


Biliary tract cancer remains serious, the diagnosis is often delayed and surgery remains the treatment of choice.